Clinical correlates of splenic histopathology and splenic karyotype in myelofibrosis with myeloid metaplasia

被引:33
作者
Mesa, RA
Li, CY
Schroeder, G
Tefferi, A
机构
[1] Mayo Clin, Div Hematol & Internal Med, Rochester, MN 55905 USA
[2] Mayo Clin, Div Hematopathol, Rochester, MN USA
[3] Mayo Clin, Ctr Canc, Stat Unit, Rochester, MN USA
关键词
D O I
10.1182/blood.V97.11.3665
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Splenic extramedullary hematopoiesis is an integral component of myelofibrosis with myeloid metaplasia (MMM) and may be classified into 3 distinct histologic patterns of infiltration by myeloid precursors: diffuse, nodular, and a predominance of immature granulocytes, These 3 histologic patterns occurred in 121 (56.8%), 75 (35.2%), and 17 (8%), respectively, of 213 patients with MMM who underwent splenectomy at a single institution. In general, karyotypic findings in splenic tissue (n = 92) were similar to those seen in the bone marrow. The histologic pattern of immature granulocyte predominance, the presence of microscopic splenic infarcts (26 patients), or the detection of an abnormal splenic karyotype (52 patients) was significantly associated with decreased postsplenectomy survival. These adverse features were also associated with characteristics of advanced disease. These observations support the bone marrow origin of the myeloid progenitor pool in the spleen of patients with MMM and suggest a prognostic value for splenic histopathology and karyotype.
引用
收藏
页码:3665 / 3667
页数:3
相关论文
共 16 条
  • [1] Assessment of the contribution of the spleen to granulocytopoiesis and erythropoiesis of the mid-gestation human fetus
    Calhoun, DA
    Li, Y
    Braylan, RC
    Christensen, RD
    [J]. EARLY HUMAN DEVELOPMENT, 1996, 46 (03) : 217 - 227
  • [2] SOME SPECULATIONS ON THE MYELOPROLIFERATIVE SYNDROMES
    DAMESHEK, W
    [J]. BLOOD, 1951, 6 (04) : 372 - 375
  • [3] THE KINETICS OF MURINE HEMATOPOIETIC STEM-CELLS IN-VIVO IN RESPONSE TO PROLONGED INCREASED MATURE BLOOD-CELL PRODUCTION INDUCED BY GRANULOCYTE-COLONY-STIMULATING FACTOR
    DEHAAN, G
    DONTJE, B
    ENGEL, C
    LOEFFLER, M
    NIJHOF, W
    [J]. BLOOD, 1995, 86 (08) : 2986 - 2992
  • [4] BLOOD AND SPLEEN HEMATOPOIESIS IN PATIENTS WITH MYELOFIBROSIS
    DOUAY, L
    LAPORTE, JP
    LEFRANCOIS, G
    NAJMAN, A
    DUPUYMONTBRUN, MC
    LOPEZ, M
    GIARRATANA, MC
    GORIN, NC
    [J]. LEUKEMIA RESEARCH, 1987, 11 (08) : 725 - 730
  • [5] Dupriez B, 1996, BLOOD, V88, P1013
  • [6] MYELOID PROGENITOR CELLS IN THE CIRCULATION OF PATIENTS WITH MYELOFIBROSIS AND OTHER MYELOPROLIFERATIVE DISORDERS
    HIBBIN, JA
    NJOKU, OS
    MATUTES, E
    LEWIS, SM
    GOLDMAN, JM
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1984, 57 (03) : 495 - 503
  • [7] NONPARAMETRIC-ESTIMATION FROM INCOMPLETE OBSERVATIONS
    KAPLAN, EL
    MEIER, P
    [J]. JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1958, 53 (282) : 457 - 481
  • [8] SPLENIC EXTRAMEDULLARY HEMATOPOIESIS IN A PATIENT RECEIVING INTERMITTENTLY ADMINISTERED GRANULOCYTE-COLONY-STIMULATING FACTOR
    LITAM, PP
    FRIEDMAN, HD
    LOUGHRAN, TP
    [J]. ANNALS OF INTERNAL MEDICINE, 1993, 118 (12) : 954 - 955
  • [9] OKEANE JC, 1989, CANCER, V63, P1539
  • [10] Porcu P, 1999, BLOOD, V93, P2132